|
2024
|
Invention
|
Antibody capable of binding to thymic stromal lymphopoietin and use thereof.
Disclosed are an an... |
|
2023
|
Invention
|
Use of combination of anti-pd-1 antibody and vegfr inhibitor in preparation of drug for treating ... |
|
2022
|
Invention
|
Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (rory) and phar... |
|
|
Invention
|
Use of ezh2 inhibitor in preparation of drug for treating t-cell lymphoma.
The present invention... |
|
|
Invention
|
Il-5 antibody, antigen binding fragment thereof, and medical application therefor.
Provided are ... |
|
2021
|
Invention
|
Nitrogen-containing bridged heterocyclic compound, preparation method therefor, and medical use t... |
|
|
Invention
|
Purinone compound, preparation method therefor, and pharmaceutical application thereof. A purinon... |
|
|
Invention
|
Crystal form of pyrimido five-membered nitrogen heterocyclic derivative and preparation method th... |
|
|
Invention
|
Use of nk1 antagonist prodrug compound in combination with 5-ht3 receptor antagonist. The present... |
|
|
Invention
|
Complex of anti-il-4r antibody or antigen-binding fragment thereof and medical use thereof. Provi... |
|
|
Invention
|
Purinone derivative, preparation method therefor, and application thereof in medicine. A purinone... |
|
|
Invention
|
Pharmaceutically acceptable salt of indazole derivative, and crystalline form and preparation met... |
|
|
Invention
|
Application of jak inhibitor in kidney disease. Provided is an application of a JAK inhibitor in ... |
|
|
Invention
|
Pharmaceutical composition for pulmonary delivery. A dry powder particle for pulmonary delivery, ... |
|
|
Invention
|
Machine learning-based peptide immunogenicity prediction and identification system and method. A ... |
|
|
Invention
|
Pharmaceutical composition comprising anti-connective tissue growth factor antibody. Provided is ... |
|
|
Invention
|
Multispecific antigen binding protein. Provided is a multispecific antigen binding protein. Provi... |
|
|
Invention
|
Drug conjugate of eribulin derivative, preparation method therefor and application thereof in med... |
|
|
Invention
|
Anti-angptl3 antibody and use thereof.
The present invention relates to an anti-ANGPTL3 antibody... |
|
|
Invention
|
Cephalosporin antibacterial compound and pharmaceutical application thereof.
Provided are a ceph... |
|
|
Invention
|
Anti-trop-2 antidody-exatecan analog conjugate and medical use thereof.
Provided in the present ... |
|
|
Invention
|
Tricyclic tetrahydroisoquinoline derivative, preparation method therefor and application thereof ... |
|
|
Invention
|
New polypeptide complex.
The present disclosure relates to a new polypeptide complex. Specifical... |
|
2020
|
Invention
|
Crystal form of pyridopyrimidine derivative and preparation method thereof.
The present disclosu... |
|
|
Invention
|
Jak kinase inhibitor pharmaceutical composition.
A JAK kinase inhibitor pharmaceutical compositi... |
|
|
Invention
|
Anti-cea antibody-exatecan analog conjugate and pharmaceutical use thereof.
An anti-CEA antibody... |
|
|
Invention
|
Anti-claudin antibody-drug conjugate and pharmaceutical use thereof.
An anti-claudin antibody-dr... |
|
|
Invention
|
Echinocandin analogues and preparation method therefor.
The present invention relates to an echi... |
|
|
Invention
|
Fused pyridine ring derivative, preparation method therefor, and pharmaceutical use thereof.
A f... |
|
|
Invention
|
Pyrazolo-heteroaryl derivative, preparation method therefor, and medical use thereof.
Disclosed ... |
|
|
Invention
|
Acid addition salt of rory regulator.
An acid addition salt of a RORγ regulator. Specifically re... |
|
|
Invention
|
Method for treating autoimmune disease by il-17 antagonist.
The present application relates to a... |
|
|
Invention
|
Neurokinin-1 antagonist.
A compound represented by formula II or a pharmaceutically acceptable s... |
|
|
Invention
|
Sustained-release lipid composition and preparation method therefor.
Disclosed are a sustained-r... |
|
|
Invention
|
Anti-cea antibody and application thereof.
Provided is an anti-CEA antibody comprising a heavy c... |
|
|
Invention
|
Indazole derivative, preparation method therefor, and pharmaceutical application thereof.
An ind... |
|
|
Invention
|
Anti-connective tissue growth factor antibody and application thereof.
Provided are an anti-CTGF... |
|
|
Invention
|
Solid dispersion and preparation method therefor.
Solid dispersion and a preparation method ther... |
|
|
Invention
|
Anti-claudin 18.2 antibody and application thereof.
The present disclosure relates to an anti-Cl... |
|
|
Invention
|
Thienoheterocyclic derivative, preparation method therefor and medical use thereof.
Provided are... |
|
|
Invention
|
Pyrroloheterocyclic derivative, preparation method therefor, and application thereof in medicine.... |
|
|
Invention
|
Bispecific antibody specifically bound to vegf and ang2.
The present disclosure provides a bispe... |
|
|
Invention
|
Bifunctional fusion protein and pharmaceutical use thereof.
Provided are a bifunctional fusion p... |
|
2019
|
Invention
|
Cd3 antibody and pharmaceutical use thereof.
The present disclosure relates to a CD3 antibody an... |
|
|
Invention
|
Cd40 antibody pharmaceutical composition and use thereof.
The present invention provides a pharm... |
|
|
Invention
|
Anti-cd73 antibody, antigen-binding fragment thereof and application thereof.
Provided are an an... |
|
|
Invention
|
Use of anti-pd-1 antibody in combination with famitinib in preparation of drug for treating tumor... |
|
|
Invention
|
Anti-cd38 antibody, antigen-binding fragment thereof, and pharmaceutical use.
The present applic... |
|
|
Invention
|
Isolated chimeric antigen receptor, modified t cell comprising same and use thereof.
An isolated... |
|
2017
|
G/S
|
Injection for pharmaceutical purposes; troche for
pharmaceutical purposes; ointment for pharmace... |
|
|
G/S
|
Cefalexin for suspension. |
|
2010
|
G/S
|
Medicines for human purposes; medicines based on raw
materials; troche for pharmaceutical purpos... |
